Upcoming Allied Market Research
Artificial Respirator Market

Artificial Respirator Market

Global Opportunity Analysis and Industry Forecast, 2022-2029

Report Code: A10877
Pages: NA
Nov 2022 | 810 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Artificial Respirator Market

Request Now !

Artificial respiration is means of assisting or stimulating respiration, a metabolic process referring to the overall exchange of gases in the body by pulmonary ventilation, external respiration, and internal respiration. It may take the form of manually providing air for a person who is not breathing or is not making sufficient respiratory effort, or it may be mechanical ventilation involving the use of a mechanical ventilator to move air in and out of the lungs when an individual is unable to breathe on their own, this machine is called ventilator; for example, during surgery with general anesthesia or when an individual is in a coma or trauma. Such methods, whenever connected rapidly and appropriately, can avert a few deaths from strangulation, drowning, choking, carbon monoxide poisoning, suffocation, and electric shock. Revival by prompting fake breath comprises primarily of two activities: setting up and keeping up an outside entry from the upper respiratory tract (throat, pharynx, and mouth) to the lungs and other is trading air and carbon dioxide in terminal air sacs of the lungs while heart is as yet working.

Market scope and structural analysis:

Report Metric


  Market size available for years 


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Type, Material, End-users, Region

  Regions covered

•North America (U.S., Canada, Mexico)

•Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)

•LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

CareFusion, Air Liquide Healthcare, Fisher & Paykel Healthcare, HOFFRICHTER GmbH, Drager, Phillips, ResMed,  Ambu, Acutronic Medical Systems, GaleMed.


Covid-19 Scenario analysis:

Out of 20% of those infected in the current pandemic, the SARS CoV-2 viruses are lodged deep in the lungs, since COVID-19 mainly affects the lower respiratory tract. Then the illness quickly becomes critical, and the most severe cases must be immediately connected to a ventilator in the intensive care unit. Because there are too few intensive care beds with ventilators even in high-technology countries such as Italy and Spain, doctors are increasingly having to decide who gets the lifesaving treatment and who doesn't. Artificial respiration can save lives because if breathing stops, the organs are no longer supplied with oxygen. At the same time, the carbon dioxide produced during breathing is no longer exhaled via the lungs. A short time after a respiratory arrest, the heart also stops beating and the circulation ceases, so that the patient dies within minutes. During the coronavirus crisis, the demand for ventilators has increased dramatically because the health care systems in many countries are not geared to the need for so many respirators simultaneously. However, such high-performance ventilators for intensive care use, which cost up to €50,000 ($55,842) apiece, cannot be purchased at short notice. There are only a few manufacturers of ventilators and so-called ECMO devices, which can enrich the blood with oxygen, i.e. work as an artificial lung. Although these companies have increased their production capacities to the maximum, there are still supply bottlenecks, including for consumables such as breathing tubes and cannulas. Dramatic shortfalls in the care of seriously ill COVID-19 patients can also occur if, for example, illness or quarantine leads to a lack of highly qualified personnel who can reliably operate these sometimes highly complex devices in intensive care. Critically ill COVID-19 patients need artificial respiration. But there is a worldwide lack of equipment.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:


Climate change and pollution increasing Respiratory disorders:

Changes in climate constitute a reality that, according to recent projections, is going to worsen in the coming years. Climate change represents a massive threat to respiratory health: 1) by directly promoting or aggravating respiratory diseases; or 2) by increasing exposure to risk factors for respiratory diseases. Climate change increases the amount of pollen and allergen produced by each plant, mold proliferation and the concentrations of outdoor ozone and particulate matter at ground level. The main diseases of concerns are asthma, rhino sinusitis, chronic obstructive pulmonary disease (COPD) and respiratory tract infections. Groups at higher risk of climate change effects include individuals with pre-existing cardiopulmonary diseases or disadvantaged individuals. Adaptation and mitigation measures are strongly needed but also the need for artificial

Technological advancement:

A new technology that re-creates important characteristics of structures in the lung could eventually be a safer alternative to certain types of respiratory and cardiac machines used to treat people whose lungs have failed due to disease or injury. An alternative to mechanical ventilation is extracorporeal membrane oxygenation (ECMO), which entails drawing a patient’s blood and running it through a device that removes carbon dioxide and adds oxygen to it before returning the blood to the patient’s body. Traditionally, ECMO has been used mainly as a life-saving measure if mechanical ventilation doesn’t work or is impossible, and is more commonly used in children. Today’s ECMO machines, in which blood flows over a bundle of porous fibers through which oxygen is pumped, are complicated and require specialized expertise to operate. Blood tends to clot in the device, which is very unlike the environment in the lung, so patients must take large doses of anti-clotting medication. This can lead to other dangerous complications such as bleeding in the brain or gastrointestinal system. The technological advancements in respiratory devices globally will drive the market growth. The combination of healthcare and technology has resulted into software applications that collects the data from the respirator attached to ventilators. The data is used to provide appropriate treatment to the patient. Other advances include nasal cannula, oxygen regulator, trans-tracheal catheter that prove beneficial for artificial delivery of oxygen. Such developments will prove beneficial for artificial respirator industry.


However, stringent government regulations related to product approvals may hamper the growth of artificial respirator market over the analysis timeframe.

Key segments covered:




  • Constant pressure type
  • Constant volume type


  • Silicon
  • PVC
  • Rubber

  End User

  • Hospitals & clinics
  • Research institutes
  • Ambulatory surgical centers
  • Others


  • North America
  • Europe
  • Asia-Pacific


Key benefits of the report:

  • This study presents the analytical depiction of the global artificial respirator industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global artificial respirator market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global artificial respirator market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the artificial respirator market.
  • The report provides a detailed global artificial respirator market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the artificial respirator market research report:

  • Which are the leading market players active in the artificial respirator market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Artificial Respirator Market Report Highlights

Aspects Details
By Type
  • Constant pressure type
  • Constant volume type
By Material
  • Silicon
  • PVC
  • Rubber
By End User
  • Hospitals & clinics
  • Research institutes
  • Ambulatory surgical centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players CareFusion,, Air Liquide Healthcare,, Fisher & Paykel Healthcare,, HOFFRICHTER GmbH,, Drager,, Phillips,, ResMed,, Ambu,, Acutronic Medical Systems,, GaleMed.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Artificial Respirator Market

Start reading.
This Report and over 19,320+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers